Breakout Stocks Gaining Momentum

Three Breakout Stocks You Should Have on Your Radar Right Now

Jupiter Neurosciences (NASDAQ: JUNS) Enters Consumer Market with Nugevia™

Jupiter Neurosciences, Inc. (NASDAQ: JUNS) has officially announced the Q3 2025 commercial launch of Nugevia™, a pharmaceutical-grade longevity product line powered by its proprietary JOTROL™ delivery technology. Originally developed to improve bioavailability in CNS drugs, JOTROL™ is now being applied to wellness products targeting mitochondrial function, cognitive clarity, and skin vitality.

The Nugevia launch is a key turning point for Jupiter, marking the company’s transition from a pure clinical-stage biotech to a revenue-generating dual-path model. Backed by eight years of pharmaceutical R&D, the new line brings clinical standards to the fast-growing $8 trillion longevity market. Proceeds from sales will directly support Jupiter’s ongoing therapeutic programs in Alzheimer’s and Parkinson’s disease.

Incannex Healthcare (NASDAQ: IXHL) Expands Advisory Board as Sleep Apnea Drug Nears Data Readout

Incannex Healthcare Inc. (NASDAQ: IXHL) is preparing for a major summer catalyst with topline Phase 2 data expected in July for IHL-42X, its once-daily oral treatment for obstructive sleep apnea (OSA). To strengthen its clinical strategy, IXHL has added four top-tier experts to its advisory board, including leaders from Harvard Medical School and Emory University.

IHL-42X takes a unique dual-mechanism approach to treating OSA by targeting intermittent hypoxia and hypercapnia—the core physiological disturbances of the disease. In earlier trials, the drug showed up to a 51% reduction in apnea severity. With over 1 billion people affected by OSA globally—and a large share at healthy weight and poorly served by current devices—Incannex is positioned to disrupt a massively underaddressed market.

DevvStream (NASDAQ: DEVS) Accelerates Asia Expansion with Indonesian Waste-to-Energy Projects

DevvStream Corp. (NASDAQ: DEVS), a leader in carbon asset development and monetization, has signed two new memoranda of understanding for waste-to-energy (WtE) projects in Indonesia. These deals, with PT Tren Solusi Transformasi Indonesia and PT Kartika Satu Graha Mandiri, will generate International Renewable Energy Certificates (I-RECs) and verified carbon credits once finalized.

The projects are part of DevvStream’s broader Southeast Asia strategy, which already includes hydroelectric assets in South Sulawesi and a solar collaboration in the Philippines. With the ASEAN WtE market projected to grow from $4.2 billion in 2025 to $7.7 billion by 2030, DEVS is planting firm roots in a high-growth vertical. The company’s diversified revenue mix now spans hydro, solar, carbon sequestration, and biogas—creating an increasingly attractive footprint for sustainability-focused investors.

Why JUNS, IXHL, and DEVS Are Worth Watching

From unlocking new revenue with clinically-backed wellness products, to redefining treatment options for a widespread sleep disorder, to scaling high-integrity carbon and renewable projects in Asia—Jupiter Neurosciences, Incannex Healthcare, and DevvStream are all positioned for pivotal moves in 2025. Each company is targeting multibillion-dollar global sectors with real momentum and upcoming catalysts, making them top watchlist material for investors focused on growth, innovation, and impact.

Unlock the power of AI-driven trading with VipLiveAlerts-Pro and stay ahead of the market with real-time alerts and expert insights—join today and transform your trading strategy!

Disclaimer: This content provides informational insights. Always conduct independent research before making investment decisions. Past performance is not indicative of future results.